Innovation
Regulatory Science and Reimbursement Learning Series
Health Economics & Reimbursement
Episodes
The State of the Financial Ecosystem: The Evolving Venture Model
53 min.
Clinical Research Areas and Funding
10 min.
Government Policies and Preferences
12 min.
Diversity and Inclusion: Implications for RCTs and Work Force Considerations
35 min.
FDA and Diversity Initiatives
8 min.
Clinician Perspectives
9 min.
Industry Perspectives
9 min.
Overcoming the "Credibility Crisis" of Observational Data
13 min.
FDA Perspectives
8 min.
The FDA Total lifecycle Advisory Program (FDA-TAP)
36 min.
Understanding the New Technology Add-on Payments Program (NTAP)
9 min.
Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET)
10 min.
The Projected Burden of Heart Failure
8 min.
Are All Incentives Altruistic?: The Importance of Measurement
8 min.
Medicare Coverage and Postmarket Evidence on Emerging Cardiovascular Devices
8 min.
Who Bears the Cost of Innovation?
9 min.
A Payors Perspective: Innovative Models to Reduce Cost
9 min.